Tracing the European course of cardiac resynchronization therapy from 2006 to 2008

Bela Merkely, Attila Roka, Valentina Kutyifa, Lucas Boersma, Antoine Leenhardt, Andrzej Lubinski, Ali Oto, Alessandro Proclemer, Josep Brugada, Panos E. Vardas, Christian Wolpert

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Cardiac resynchronization therapy (CRT) is a highly efficient treatment modality for patients with severe congestive heart failure and intraventricular dyssynchrony. However, the high individual cost and technical complexity of the implantation may limit its widespread utilization. The European Heart Rhythm Association (EHRA) launched a project to assess treatment of arrhythmias in all European Society of Cardiology member countries in order to have a platform for a progressive harmonization of arrhythmia treatment. As a result, two EHRA White Books have been published in 2008 and 2009 based on governmental, insurance, and professional society data. Our aim was to analyse the local differences in the utilization of CRT, based on these surveys. A total of 41 countries provided enough data to analyse years 2006-2008. Significant differences were found in the overall number of implantations and the growth rate between 2006 and 2008. Other contributing factors include local reimbursement of CRT, the existence of national guidelines, and a high number of conventional implantable cardioverter-defibrillator implantations, while GDP or healthcare spending has less effect. Focusing on improving these factors may increase the availability of CRT in countries where it is currently underutilized.

Original languageEnglish (US)
Pages (from-to)692-701
Number of pages10
JournalEuropace
Volume12
Issue number5
DOIs
StatePublished - May 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Tracing the European course of cardiac resynchronization therapy from 2006 to 2008'. Together they form a unique fingerprint.

Cite this